Market Report

Market Report by Email

If you would like to receive the daily Market Report by email please fill out your name and email address in the sign-up form below and you will be added to our mailing list.

* indicates required

Please select all the ways you would like to hear from Ramsey Crookall:

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

We use Mailchimp as our email marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing.

Learn more about Mailchimp's privacy practices here.

Tuesday,09 July 2024 at 15:51

European stocks were lower Tuesday, as investors in the region weigh up political uncertainty in France after Sunday’s election result. The left-wing New Popular Front won the largest number of seats in the final round of voting. The alliance failed to secure an absolute majority, however, meaning a coalition or technocratic government is on the cards, making legislation and reforms harder to pass.

The S&P 500 and the Nasdaq hit record highs on Tuesday, powered by semiconductors and megacaps, as Congress heard testimony from Federal Reserve Chair Jerome Powell, who said more "good" economic data would strengthen the case for interest-rate cuts.

The dollar gained on Tuesday after Federal Reserve Chair Jerome Powell acknowledged progress in inflation, but did not give a clear signal that the U.S. central bank is close to cutting interest rates.

Oil prices fell for the third straight session on Tuesday, as Gulf Coast production and refining infrastructure appears to have avoided substantial damage from Tropical Storm Beryl.

Gold retreated after it became clear that was unlikely to be an imminent cut in US interest rates.

In market news:


BP fell 3.93% after the oil major said in a trading statement it expected a second-quarter earnings hit of $1 billion to $2 billion from impairments, and of $500 million to $700 million due to “significantly lower realized refining margins.”

Shares in Novo Nordisk, which makes the obesity drug Wegovy, fell 1.5% after analysis by the JAMA Internal Medicine journal indicated that Wli Lilly's rival treatment led to greater weight loss.

Markets
16.30
FTSE 100 8,135 (-0.70%)
FTSE 250 20,619 (-0.86%)
DAX 18,226 (-1.33%)
16.34
Dow Jones 39,249 (-0.24%)
S&P 500 5,581 +0.15%
NASDAQ 18,447 +0.24%
Fixed Income
UK 10-YR YIELD 4.166
Exchange Rates
GBP/USD 1.278
GBP/EUR 1.182
Commodities
Gold $2,354 (-0.15%)
Brent $84.74 (-1.02%)
Important - No news or research item should be construed as a recommendation to trade. The inclusion of securities within this report does not necessarily imply their suitability for individual portfolios or situations in respect of which further advice should be sought. Information contained in this report has been compiled from sources believed to be reliable but is not warranted to be accurate or complete.

We use cookies to improve your experience on our website.
By continuing to browse, you agree to our use of cookies. Cookie Policy

Accept
Members of the London Stock Exchange and PIMFA | Licensed by the Isle of Man Financial Services Authority (IoMFSA) Registered Office: Ramsey Crookall and Co. Ltd., 38/42 Athol Street, Douglas, Isle of Man, IM1 1QH
Copyright © 2023 - Ramsey Crookall & Co. Ltd
Building Personal Finance Futures London Stock Exchange